Delaware
|
000-50590
|
11-3516358
|
(State
or Other Jurisdiction of
Incorporation)
|
(Commission
File
Number)
|
(I.R.S.
Employer Identification
No.)
|
¨
|
Written
communications pursuant to Rule 425 under the Securities Act (17
CFR
230.425)
|
¨
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
¨
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR
240.14d-2(b))
|
¨
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR
240.13e-4(c))
|
(d) |
Exhibits.
|
99 |
Press
Release of the Company dated June 15,
2007.
|
REXAHN
PHARMACEUTICALS, INC.
|
|||
(Registrant)
|
|||
By
|
/s/
Chang H. Ahn
|
||
Chang
H. Ahn
|
|||
Chairman
and Chief Executive
Officer
|
Date:
|
June
15, 2007
|
Exhibit
Number
|
Description
|
|
Press
release of the Company dated June 15, 2007.
|